| Etanercept in children with polyarticular juvenile rheumatoid arthritis DJ Lovell, EH Giannini, A Reiff, GD Cawkwell, ED Silverman, JJ Nocton, ... New England Journal of Medicine 342 (11), 763-769, 2000 | 1613 | 2000 |
| Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus HI Brunner, DD Gladman, D Ibañez, MD Urowitz, ED Silverman Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 617 | 2008 |
| Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test AC Lionel, G Costain, N Monfared, S Walker, MS Reuter, SM Hosseini, ... Genetics in Medicine 20 (4), 435-443, 2018 | 531 | 2018 |
| A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis N Ruperto, DJ Lovell, R Cuttica, N Wilkinson, P Woo, G Espada, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 498 | 2007 |
| Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study LT Hiraki, SM Benseler, PN Tyrrell, D Hebert, E Harvey, ED Silverman The Journal of pediatrics 152 (4), 550-556, 2008 | 441 | 2008 |
| Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: a single institution’s experience of 30 years ET Jaeggi, RM Hamilton, ED Silverman, SA Zamora, LK Hornberger Journal of the American College of Cardiology 39 (1), 130-137, 2002 | 438 | 2002 |
| Factors influencing success of clinical genome sequencing across a broad spectrum of disorders JC Taylor, HC Martin, S Lise, J Broxholme, JB Cazier, A Rimmer, ... Nature genetics 47 (7), 717-726, 2015 | 418 | 2015 |
| Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease ET Jaeggi, JC Fouron, ED Silverman, G Ryan, J Smallhorn, ... Circulation 110 (12), 1542-1548, 2004 | 417 | 2004 |
| Prevalence and burden of pediatric-onset systemic lupus erythematosus S Kamphuis, ED Silverman Nature Reviews Rheumatology 6 (9), 538-546, 2010 | 396 | 2010 |
| Risk factors for damage in childhood‐onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage HI Brunner, ED Silverman, T To, C Bombardier, BM Feldman Arthritis & Rheumatism 46 (2), 436-444, 2002 | 364 | 2002 |
| Leflunomide or methotrexate for juvenile rheumatoid arthritis E Silverman, R Mouy, L Spiegel, LK Jung, RK Saurenmann, P Lahdenne, ... New England journal of medicine 352 (16), 1655-1666, 2005 | 361 | 2005 |
| Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long‐term followup study RK Saurenmann, AV Levin, BM Feldman, JB Rose, RM Laxer, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 358 | 2007 |
| Transancestral mapping and genetic load in systemic lupus erythematosus CD Langefeld, HC Ainsworth, DSC Graham, JA Kelly, ME Comeau, ... Nature communications 8 (1), 16021, 2017 | 351 | 2017 |
| Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor RK Saurenmann, JB Rose, P Tyrrell, BM Feldman, RM Laxer, ... Arthritis & Rheumatism 56 (6), 1974-1984, 2007 | 350 | 2007 |
| Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Annals of the rheumatic diseases 74 (6), 1110-1117, 2015 | 310 | 2015 |
| The role of antimalarial agents in the treatment of SLE and lupus nephritis SJ Lee, E Silverman, JM Bargman Nature Reviews Nephrology 7 (12), 718-729, 2011 | 307 | 2011 |
| Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies R Cimaz, DL Spence, L Hornberger, ED Silverman The Journal of pediatrics 142 (6), 678-683, 2003 | 306 | 2003 |
| The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 … E Jaeggi, C Laskin, R Hamilton, J Kingdom, E Silverman Journal of the American College of Cardiology 55 (24), 2778-2784, 2010 | 293 | 2010 |
| Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus CO Jacob, J Zhu, DL Armstrong, M Yan, J Han, XJ Zhou, JA Thomas, ... Proceedings of the National Academy of Sciences 106 (15), 6256-6261, 2009 | 287 | 2009 |
| Tumour necrosis factor α inhibitors in the treatment of childhood uveitis RK Saurenmann, AV Levin, JB Rose, S Parker, T Rabinovitch, PN Tyrrell, ... Rheumatology 45 (8), 982-989, 2006 | 286 | 2006 |
